214 related articles for article (PubMed ID: 26176734)
1. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.
Zheng X; Chen S; Yang Q; Cai J; Zhang W; You H; Xing J; Dong Y
Cancer Biol Ther; 2015; 16(9):1407-14. PubMed ID: 26176734
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
[TBL] [Abstract][Full Text] [Related]
3. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
[TBL] [Abstract][Full Text] [Related]
4. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.
Chen S; Dong Q; Hu S; Cai J; Zhang W; Sun J; Wang T; Xie J; He H; Xing J; Lu J; Dong Y
Mol Biosyst; 2014 Feb; 10(2):294-303. PubMed ID: 24292090
[TBL] [Abstract][Full Text] [Related]
6. Bioreducible and acid-labile polydiethylenetriamines with sequential degradability for efficient transgelin-2 siRNA delivery.
Wang P; Yan Y; Sun Y; Zhang R; Huo C; Li L; Wang K; Dong Y; Xing J
J Mater Chem B; 2019 Nov; 7(44):6994-7005. PubMed ID: 31625545
[TBL] [Abstract][Full Text] [Related]
7. Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway.
Liu L; Meng T; Zheng X; Liu Y; Hao R; Yan Y; Chen S; You H; Xing J; Dong Y
Mol Cancer Ther; 2019 Dec; 18(12):2457-2468. PubMed ID: 31488699
[TBL] [Abstract][Full Text] [Related]
8. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
10. Transgelin Silencing Induces Different Processes in Different Breast Cancer Cell Lines.
Dvorakova M; Lapcik P; Bouchalova P; Bouchal P
Proteomics; 2020 Apr; 20(7):e1900383. PubMed ID: 32061197
[TBL] [Abstract][Full Text] [Related]
11. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer.
Ji X; Peng Z; Li X; Yan Z; Yang Y; Qiao Z; Liu Y
Cancer Lett; 2017 Feb; 386():24-34. PubMed ID: 27832973
[TBL] [Abstract][Full Text] [Related]
14. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells.
Wang X; Wang C; Zhang L; Li Y; Wang S; Wang J; Yuan C; Niu J; Wang C; Lu G
Anticancer Drugs; 2015 Feb; 26(2):210-23. PubMed ID: 25419632
[TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction.
Zhong W; Sun B; Gao W; Qin Y; Zhang H; Huai L; Tang Y; Liang Y; He L; Zhang X; Tao H; Chen S; Yang W; Yang L; Liu Y; Liu H; Zhou H; Sun T; Yang C
EBioMedicine; 2018 Nov; 37():246-258. PubMed ID: 30361065
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
19. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
20. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.
Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y
Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
